The evaluation of sovateltide’s effects on ETB receptor expression, VEGF, NGF, oxidative stress markers, and DNA fragmentation in a Rice–Vannucci rat model of HIE has offered valuable insights into its potential as a therapeutic agent for HIE [148,162,163]. This evidence concerns the gene VEGFA and perinatal asphyxia.